{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "MSEPO-21047 Health clearance and management of HCW with bloodborne viruses 1.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 15,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "POLICY FOR THE HEALTH CLEARANCE AND MANAGEMENT OF HEALTH CARE WORKERS LIVING WITH BLOODBORNE VIRUSES (HEPATITIS B, HEPATITIS C AND HIV)"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "MSEPO-21047"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP/CCP)"
                    },
                    {
                        "text": "Policy"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "All staff"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "20 April 2021"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "19 April 2024"
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "Public Health England (2020)"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Human Resources"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Teresa Dowdeswell, Occupational Health Site Lead"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2612 MSE NHS Foundation Trust \u2610 Basildon Hospital \u2610 Broomfield Hospital \u2610 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "Infection Control Committee HR Policy Working Group"
                    },
                    {
                        "text": "15 April 2021 08 April 2021"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Kelly McClenaghan, Interim AD Occupational Health and Wellbeing"
                    },
                    {
                        "text": "15 April 2021"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "20 April 2021"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Document Ratification Group)"
                    },
                    {
                        "text": "April 2021"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "\u2612 Trust Intranet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "MSEPO-21047 Health clearance and management of HCW with bloodborne viruses 1.0.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 12,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Consulted With: this must include Pharmacy if the document has any reference to medication"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Dr Awad-el-karim"
                    },
                    {
                        "text": "Director of Infection Prevention and Control"
                    },
                    {
                        "text": "14 January 2021"
                    },
                    {
                        "text": "Cheryl Schwarz, Yvonne Brierly, Dawn Patience"
                    },
                    {
                        "text": "Directors of Nursing"
                    },
                    {
                        "text": "14 January 2021"
                    },
                    {
                        "text": "Emma Dowling"
                    },
                    {
                        "text": "Head of Infection Control and Prevention"
                    },
                    {
                        "text": "14 January 2021"
                    },
                    {
                        "text": "Dr Leighton, Dr Boakye, Dr Elekima"
                    },
                    {
                        "text": "Occupational Health Physicians"
                    },
                    {
                        "text": "13 January 2021"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Site Lead Group (OH)"
                    },
                    {
                        "text": "13 January 2021"
                    },
                    {
                        "text": "Dr Day"
                    },
                    {
                        "text": "HIV Consultant"
                    },
                    {
                        "text": "14 January 2021"
                    },
                    {
                        "text": "Dr Ahmed"
                    },
                    {
                        "text": "Microbiologist"
                    },
                    {
                        "text": "14 January 2021"
                    },
                    {
                        "text": "Simon Worrell"
                    },
                    {
                        "text": "Pharmacy Lead"
                    },
                    {
                        "text": "14 January 2021"
                    },
                    {
                        "text": "Jennifer Canham"
                    },
                    {
                        "text": "HR"
                    },
                    {
                        "text": "14 January 2021"
                    },
                    {
                        "text": "Laura Hilton"
                    },
                    {
                        "text": "HIV lead nurse"
                    },
                    {
                        "text": "14 January 2021"
                    },
                    {
                        "text": "Samson DeAlyn"
                    },
                    {
                        "text": "HR Policy Working Group"
                    },
                    {
                        "text": "08 April 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "Staff immunisation and health screening policy or equivalent Needlestick policy or equivalent"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 5,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Teresa Dowdeswell"
                    },
                    {
                        "text": "20 April 2021"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Contents"
            },
            "type": "ListItem",
            "sequence_num": 7
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "In the UK, the policy on the management of health care workers (HCWs) infected with bloodborne viruses (BBVs), namely hepatitis B (HBV), hepatitis C (HCV) and human immunodeficiency virus (HIV) was precautionary and conservative in the first instance. These have however, evolved over time guided by merging evidence on the risk of HCWs transmitting bloodborne viruses (BBVs) to their patients, experience of patient notification exercises (PNEs) and the recommendations of the Expert Advisory Group on AIDS (EAGA), the Expert Advisory Group on Hepatitis (EGH) and the UK Advisory Panel for Healthcare Workers Infected with Blood borne Viruses (UKAP), who have regularly reviewed the policies for managing BBV infected HCWs."
            },
            "type": "ListItem",
            "sequence_num": 8
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "Patient safety is paramount and dependent upon the HCW's disclosure. The Trust ultimately seeks to promote a climate where HCWs living with blood borne viruses feel supported and safe to disclose medical information relating to BBVs; but it also aims to remind HCWs of the need to be aware of their BBV status and associated risks and to comply with monitoring arrangements described in the policy."
            },
            "type": "ListItem",
            "sequence_num": 9
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "The purpose of this document is to:"
            },
            "type": "ListItem",
            "sequence_num": 10
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Provide a framework for the health clearance of healthcare workers HCWs) and the management of HCWs living with blood borne viruses (BBVs), namely hepatitis B (HBV), hepatitis C (HCV) and human immunodeficiency virus (HIV)."
            },
            "type": "ListItem",
            "sequence_num": 11
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Clarify the duties of HCWs, their medical advisers and employers. It is supplementary to occupational health checks and immunisations for other infectious diseases (e.g. for tuberculosis, measles, rubella and varicella)."
            },
            "type": "ListItem",
            "sequence_num": 12
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Confirm that this policy applies to all HCWs employed by the Trust, specifically those with clinical responsibilities including visiting and locum clinical staff."
            },
            "type": "ListItem",
            "sequence_num": 13
        },
        {
            "type": "table",
            "sequence_num": 14,
            "data": {
                "num_rows": 3,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "TERM"
                    },
                    {
                        "text": "DEFINITION"
                    },
                    {
                        "text": "Exposure Prone Procedures (EPP)"
                    },
                    {
                        "text": "EPPs include procedures where the workers' gloved hands may be in contact with sharp instruments, needle tips or sharp tissues (e.g. spicules of bone or teeth) inside a patient's open body cavity, wound or confined anatomical space where the hands or fingertips may not be completely visible at all times."
                    },
                    {
                        "text": "New Healthcare Worker (HCW)"
                    },
                    {
                        "text": "A new HCW is defined as an individual who has direct clinical contact with patients in the NHS for the first time, whether as an employee or with the employer's agreement (e.g. student placements, visiting fellows). Existing HCWs who are moving to a post for training that involves EPPs for the first time in their career, are also considered as \u201cnew\u201d. Returning HCWs may also be regarded as \u201cnew\u201d depending on what activities they have"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 15,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": "engaged in while away from the health service."
                    },
                    {
                        "text": "Identified Valid Sample (IVS)"
                    },
                    {
                        "text": "An IVS is defined according to the following criteria: The employee should show proof of identity with a photograph when the sample is taken. Acceptable ID includes the following: NHS Trust identity badge Photo Drivers licence Passport National identity card The sample of blood must be taken in the OH department Samples should be delivered to the laboratory in the usual manner, not transported by the employee When results are received from the laboratory, the clinical notes should be checked for a record that the sample was sent by the OH department at the relevant time"
                    },
                    {
                        "text": "Viral Load"
                    },
                    {
                        "text": "Viral load, also known as viral burden or viral titre is a measure of the severity of an active infection and can be calculated by estimating the live amount of virus in an involved body fluid."
                    },
                    {
                        "text": "cART"
                    },
                    {
                        "text": "Combined Anti-retroviral therapy"
                    },
                    {
                        "text": "Elite Controller"
                    },
                    {
                        "text": "Elite controllers comprise a small proportion (0.2-0.55%) of all people living with HIV, who are not receiving antiretroviral therapy and have maintained their viral load below the limits of assay detection for at least 12 months, based on at least three separate viral load measurements."
                    },
                    {
                        "text": "UKAP"
                    },
                    {
                        "text": "UK Advisory Panel for health care workers infected with bloodborne viruses"
                    },
                    {
                        "text": "UKAP - OHR"
                    },
                    {
                        "text": "Occupational health monitoring register of Bloodborne Virus Infected Health Care Workers"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.1,
                "text": "Infection Prevention and Control Committee. The Director of Infection Prevention & Control and the Infection Control team will provide expert advice as appropriate in relation to matters covered in this policy."
            },
            "type": "ListItem",
            "sequence_num": 16
        },
        {
            "data": {
                "is_heading": 1,
                "text": "4.1.2 The Health and Safety Group is responsible for receiving and reviewing reports on and monitoring compliance in relation to sharps, needlestick and body fluid exposure incidents within the Trust"
            },
            "type": "ListItem",
            "sequence_num": 17
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.2,
                "text": "The Chief Executive has overall responsibility for ensuring the Trust has management systems in place to enable the effective and safe implementation of this policy, for this policy in particular this extends to establishing and maintaining IPC arrangements across the organisation. This responsibility is delegated to the Director of Infection Prevention and Control."
            },
            "type": "ListItem",
            "sequence_num": 18
        },
        {
            "data": {
                "is_heading": 1,
                "text": "4.2.1 Executive Director with responsibility for Infection Prevention and Control"
            },
            "type": "ListItem",
            "sequence_num": 19
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The Chief Nurse has delegated responsibility from the Chief Executive for the operation of this policy"
            },
            "type": "ListItem",
            "sequence_num": 20
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensures that the Trust Board is advised of the effectiveness of this policy and any shortfalls in meeting the standards set"
            },
            "type": "ListItem",
            "sequence_num": 21
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Chairs the Infection Control & Prevention Committee which will monitor compliance with the effectiveness of the policy"
            },
            "type": "ListItem",
            "sequence_num": 22
        },
        {
            "data": {
                "is_heading": 1,
                "text": "4.2.2 Department managers are responsible for ensuring:"
            },
            "type": "ListItem",
            "sequence_num": 23
        },
        {
            "data": {
                "is_heading": 0,
                "text": "That all staff are aware of the contents of this policy"
            },
            "type": "ListItem",
            "sequence_num": 24
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To ensure that the status and rights of infected HCWs as employees is safeguarded as far as is practicable. Where necessary, make every effort to arrange suitable alternative work, redeployment opportunities, or where appropriate early retirement."
            },
            "type": "ListItem",
            "sequence_num": 25
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To ensure that the individual HCWs have access to an Occupational Health Physician."
            },
            "type": "ListItem",
            "sequence_num": 26
        },
        {
            "data": {
                "is_heading": 0,
                "text": "That no healthcare worker is allowed to undertake exposure prone procedures until health clearance has been issued by Occupational Health"
            },
            "type": "ListItem",
            "sequence_num": 27
        },
        {
            "data": {
                "is_heading": 1,
                "text": "4.2.3 All employees are responsible for ensuring:"
            },
            "type": "ListItem",
            "sequence_num": 28
        },
        {
            "data": {
                "is_heading": 0,
                "text": "All HCWs are under ethical and legal duties to protect the health and safety of themselves and of others, such as colleagues and patients, and must have understanding of, and co-operate in health and safety"
            },
            "type": "ListItem",
            "sequence_num": 29
        },
        {
            "data": {
                "is_heading": 0,
                "text": "All HCWs must meet the requirements for health clearance (screening for BBVs) at the appropriate stages of their career, including training and undertaking new roles which involve EPPs. HCW's appliying for new posts should complete health questionnaires honestly."
            },
            "type": "ListItem",
            "sequence_num": 30
        },
        {
            "data": {
                "is_heading": 0,
                "text": "HCWs diagnosed with BBV must observe their duty of self-declaration to an occupational health physician to allow restriction of working practice (if required) to be implemented. HCWs are under an ongoing obligation to seek professional advice about the need to be tested if they have any reason to believe that they may have been exposted to infection with a serous communicable disease either through a specific occupational incident or outside the work environment. Failure to do so may breach the duty of care to patients."
            },
            "type": "ListItem",
            "sequence_num": 31
        },
        {
            "data": {
                "is_heading": 0,
                "text": "For those HCWs who are living with one or a combination of HIV, HBC or HCV, it is incumbent on the HCW to ensure they are assessed regularly by their treating physician and promply seek and follow expert occupational health advice. HCWs who are self employed or working as a locum via an agency should arrange to take advice from an accredited consultant occupational health physician independently if it is not provided by the locum agency or employer."
            },
            "type": "ListItem",
            "sequence_num": 32
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Those staff who perform, or who may perform EPPs must obtain further expert advice about modification or limitation of their working practices to avoid EPPs until they meet the appropriate criteria to recommence EPPs."
            },
            "type": "ListItem",
            "sequence_num": 33
        },
        {
            "data": {
                "is_heading": 0,
                "text": "That they familiarise themselves with this policy and, where additional screening and vaccinations are required in order to comply with the policy, they should arrange for these to be completed through the Occupational Health"
            },
            "type": "ListItem",
            "sequence_num": 34
        },
        {
            "data": {
                "is_heading": 1,
                "text": "4.2.4 Human Resources Department are responsible for ensuring:"
            },
            "type": "ListItem",
            "sequence_num": 35
        },
        {
            "data": {
                "is_heading": 0,
                "text": "That no staff member commences employment until an appropriate health clearance certificate has been issued by Occupational Health, including confirmation of clearance to undertake Exposure Prone Procedures (EPP). Students will have clearance from their own University Occupational Health Departments'."
            },
            "type": "ListItem",
            "sequence_num": 36
        },
        {
            "data": {
                "is_heading": 0,
                "text": "That all new starters complete a pre-employment questionnaire which is forwarded to Occupational Health for review."
            },
            "type": "ListItem",
            "sequence_num": 37
        },
        {
            "data": {
                "is_heading": 1,
                "text": "4.2.5 The Occupational Health & Wellbeing Service (OH) is responsible for:"
            },
            "type": "ListItem",
            "sequence_num": 38
        },
        {
            "data": {
                "is_heading": 0,
                "text": "All matters arising from and relating to the training and/or employment of HCWs living with BBVs is co-ordinated through an accredited consultant occupational health physician."
            },
            "type": "ListItem",
            "sequence_num": 39
        },
        {
            "data": {
                "is_heading": 0,
                "text": "While the consultant occupational health physician has responsibility for occupational medical management and assessment, if an OHP is not immediately available, HCWs may initially seek advice from occupational health nurses. The nurse will make every effort to arrange for the HCW to see the consultant occupational physician as soon as possible."
            },
            "type": "ListItem",
            "sequence_num": 40
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The Occupational health and wellbeing department (OH) is proactive in helping HCWs to assess if they have been at risk of BBV infection and encourages them to be tested, if appropriate. OH will ensure that new HCWs who intend to perform EPPs, have the necessary clearance to do so. OH will explain the testing arrangements for health clearance and how BBV infection might affect continued performance of EPPs."
            },
            "type": "ListItem",
            "sequence_num": 41
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Before HCWs living with BBVs are cleared to perform EPPs, the OH service will also follow a standard practice of checking the HCW's previous EPP history"
            },
            "type": "ListItem",
            "sequence_num": 42
        },
        {
            "data": {
                "is_heading": 0,
                "text": "After testing, OH will inform HCWs of the results of their tests and the implications for their working practice, including where appropriate any requirements for further follow up and monitoring. All HCWs living with BBVs will be given accurate and detailed advice on ways to minimise the risks of transmission in the healthcare setting and to close contacts."
            },
            "type": "ListItem",
            "sequence_num": 43
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Referral to the appropriate physician for specialist clinical assessment (if this has not already taken place) will be made by the OH service, and not by self-referral."
            },
            "type": "ListItem",
            "sequence_num": 44
        },
        {
            "data": {
                "is_heading": 1,
                "text": "4.2.6 Consultant Occupational Health Physician is responsible for the monitoring of HCW living with BBV, cleared to perform EPPs, in accordance with this policy. The HCW's treating physician is responsible for providing the necessary regular care in relation to the management of the BBV infection. The consultant occupational health physician's responsibilities include:"
            },
            "type": "ListItem",
            "sequence_num": 45
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that appointments are available for testing accordance with the testing protocol, and timings are followed"
            },
            "type": "ListItem",
            "sequence_num": 46
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Reacting promptly to any alerts received via the UKAP-OHR"
            },
            "type": "ListItem",
            "sequence_num": 47
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Taking appropriate action when those who should present for tests or not do so, e.g. notifying the relevant manager of the HCW's non- attendance and restriction from EPP practice"
            },
            "type": "ListItem",
            "sequence_num": 48
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that the UKAP-OHR is updated in a timely manner"
            },
            "type": "ListItem",
            "sequence_num": 49
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring the IVS samples are collected and tested and results obtained in a timely manner"
            },
            "type": "ListItem",
            "sequence_num": 50
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Interpreting the viral load results in relation to clearance to perform EPPs."
            },
            "type": "ListItem",
            "sequence_num": 51
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Notifying the HCW that they are cleared to perform EPPs and updating the clearance form on Cohort so that the line manager is advised"
            },
            "type": "ListItem",
            "sequence_num": 52
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring the UKAP-OHR is updated within the specified time frame."
            },
            "type": "ListItem",
            "sequence_num": 53
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Advising the employer if the HCW is no longer fit to perform EPPs"
            },
            "type": "ListItem",
            "sequence_num": 54
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Timely liaison with treating physicians when required"
            },
            "type": "ListItem",
            "sequence_num": 55
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Inform UKAP-OHR of any change of employer and provide contact detaisl for the new OH service which will be taking over monitoring of the HCW's"
            },
            "type": "ListItem",
            "sequence_num": 56
        },
        {
            "data": {
                "is_heading": 0,
                "text": "infection."
            },
            "type": "ListItem",
            "sequence_num": 57
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.1,
                "text": "Standard health clearance for all HCWs"
            },
            "type": "ListItem",
            "sequence_num": 58
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.1.1 Standard health clearance will occur for all categories of new HCWs employed in a clinical care setting, either for the first time or returning to work in the NHS as per the Trust's staff immunisation and health screening policy."
            },
            "type": "ListItem",
            "sequence_num": 59
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.1.2 All HCWs who are new to the NHS can have testing for HBV, HCV and HIV on request with the appropriate pre-test discussion in the context of their professional responsibilities."
            },
            "type": "ListItem",
            "sequence_num": 60
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.1.3 Health clearance measures for new HCWs provide protection for patients from exposure in the clinical care setting to HBV, HCV and HIV. These measures are not intended to prevent those living with BBVs from working in the NHS, but rather to restrict them from working in those clinical areas where their infection may pose a risk to patients in their care. This is consistent with restrictions imposed on the working practices of HCWs who are known to be living with a BBV."
            },
            "type": "ListItem",
            "sequence_num": 61
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.2,
                "text": "Additional health clearance for all \u201cnew HCWs\u201d who will perform EPP, and for existing HCW's who are new to EPPs."
            },
            "type": "ListItem",
            "sequence_num": 62
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.2.1 Additional health clearance is required for HCWs who will perform EPPs. Certain workers will not be able to undertake work until an appropriate identity validated blood test (IVS) is undertaken by Occupational Health to confirm their non- infectivity to Hepatitis B, Hepatitis C and HIV. These workers include:"
            },
            "type": "ListItem",
            "sequence_num": 63
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Healthcare workers starting their first EPP Nursing, Midwifery or Medical job"
            },
            "type": "ListItem",
            "sequence_num": 64
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Healthcare workers entering training for a career that relies upon the performance of EPPs"
            },
            "type": "ListItem",
            "sequence_num": 65
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Healthcare workers that have been working in a \u201chigh risk\u201d area outside the NHS"
            },
            "type": "ListItem",
            "sequence_num": 66
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Healthcare workers who are unable to produce appropriate evidence of previous test results"
            },
            "type": "ListItem",
            "sequence_num": 67
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.2.2 Healthcare workers who apply for a post which requires the performance of EPPs and who decline to be tested for HIV, Hepatitis B and Hepatitis C will not be cleared for EPP work."
            },
            "type": "ListItem",
            "sequence_num": 68
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.2.3 The time for testing new HCW's may vary depending upon the particular chosen career, but times considered appropriate are:"
            },
            "type": "ListItem",
            "sequence_num": 69
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Junior doctors entering all surgical specialties, obstetrics and gynaecology, should be tested before their first foundation house officer post (this will include those posts in accident & emergency and trauma care where doctors may be called upon to perform EPPs."
            },
            "type": "ListItem",
            "sequence_num": 70
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Prospective dental students, hygienists and therapists should be tested before entry to dental school, as EPP's form an integral part of their training and in the work of dentists."
            },
            "type": "ListItem",
            "sequence_num": 71
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Prospective midwifery students should be tested before embarking on midwifery courses."
            },
            "type": "ListItem",
            "sequence_num": 72
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Nurse should be tested before they move to specialised areas of work where they may be required to perform EPPs, eg operating theatre and accident & emergency nursing."
            },
            "type": "ListItem",
            "sequence_num": 73
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ambulance staff should be tested before they embark on training as paramedics or technicians"
            },
            "type": "ListItem",
            "sequence_num": 74
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Podiatrists should be tested before they commence training in podiatric"
            },
            "type": "ListItem",
            "sequence_num": 75
        },
        {
            "data": {
                "is_heading": 0,
                "text": "surgery."
            },
            "type": "ListItem",
            "sequence_num": 76
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.3,
                "text": "HCW's moving to a new role who have previously performed EPPs."
            },
            "type": "ListItem",
            "sequence_num": 77
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.3.1 Health care workers who move from an existing post that involves EPPs to a new post that involves EPPs will need to provided evidence of their health clearance (if they started practicing EPPs after 2007 this should be available). If evidence of clearance is not provided, then the HCW should be treated as \u201cnew\u201d and blood tests are obtained."
            },
            "type": "ListItem",
            "sequence_num": 78
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.3.2 Transferred HCWs living with a BBV from a previous OH service or healthcare organisation, should provide the following information from the previous occupational health physician:"
            },
            "type": "ListItem",
            "sequence_num": 79
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Approximate dates of employment and clearance"
            },
            "type": "ListItem",
            "sequence_num": 80
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Consent of HCW to transfer UKAP-OHR registration"
            },
            "type": "ListItem",
            "sequence_num": 81
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Confirmation that the UKAP-OHR team have been informed of the transfer"
            },
            "type": "ListItem",
            "sequence_num": 82
        },
        {
            "data": {
                "is_heading": 0,
                "text": "UKAP-OHR reference number"
            },
            "type": "ListItem",
            "sequence_num": 83
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Consent of HCW to transfer the HCWs EPP related health records"
            },
            "type": "ListItem",
            "sequence_num": 84
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Medical and treatment history including medication changes and compliance"
            },
            "type": "ListItem",
            "sequence_num": 85
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Testing history including points of note e.g. historical actions or tests needed"
            },
            "type": "ListItem",
            "sequence_num": 86
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Confirmation that the new consultant occupational physician is accredited in occupational medicine"
            },
            "type": "ListItem",
            "sequence_num": 87
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Contact details of the treating doctor"
            },
            "type": "ListItem",
            "sequence_num": 88
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Any other concerns or details necessary"
            },
            "type": "ListItem",
            "sequence_num": 89
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.4,
                "text": "Hepatitis B testing of HCWs who will perform EPP"
            },
            "type": "ListItem",
            "sequence_num": 90
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.4.1 New HCWs who intend to perform EPPs or clinical duties in renal units or any other settings involving renal dialysis will be:"
            },
            "type": "ListItem",
            "sequence_num": 91
        },
        {
            "data": {
                "is_heading": 0,
                "text": "tested for hepatitis B surface antigen (HBsAg)"
            },
            "type": "ListItem",
            "sequence_num": 92
        },
        {
            "data": {
                "is_heading": 1,
                "text": "If negative for HBsAG, offered vaccination (unless they have already received a course of vaccine) and have their response checked (anti-HBs). Where there is evidence that a HCW, who is known to have had a previous HBV infection which has cleared, now has natural immunity, immunisation is not necessary, but the advice of the local virologist or microbiologist will be sought. HCW for whom hepatitis B vaccination is contra-indicated, who decline the vaccine or who are non- responders to vaccine (i.e. with ant-HB;s levels of less thatn 10mIU/mL) will be restricted from performing EPPs or clinical duties in renal units or any other settings involving renal dialysis, unless shown to be non- infectious. They will be tested annually for HBsAg."
            },
            "type": "ListItem",
            "sequence_num": 93
        },
        {
            "data": {
                "is_heading": 0,
                "text": "HCWs initially testing positive for HBsAg, will be tested for hepatitis B viral load (HBV DNA). Those HCWs who have a HBV DNA level at or above 200 IU/mL will not be permitted to perform EPP or undertake clinical duties in renal units or any other settings involving renal dialysis regardless of treatment status."
            },
            "type": "ListItem",
            "sequence_num": 94
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Initial clearance to perform EPPs requires 2 Identified and Validated Samples (IVS) taken no less than 4 weeks apart with both showing a viral load below 200 IU/mL. The decision to clear individual HCWs to undertake EPPs or clinical duties in renal units is the responsibility of the Occupational Health Physician. UKAP can be consulted as required."
            },
            "type": "ListItem",
            "sequence_num": 95
        },
        {
            "data": {
                "is_heading": 0,
                "text": "(see section 6 for monitoring and ongoing clearance of HCW's who will be performing EPP's and are living with HBV)"
            },
            "type": "ListItem",
            "sequence_num": 96
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.5,
                "text": "Hepatitis C testing of HCWs who will perform EPP"
            },
            "type": "ListItem",
            "sequence_num": 97
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.5.1  New HCWs who intend to perform EPPs will be tested for HCV antibody. Those who are positive will be tested for HCV RNA to detect the presence of current infection. Testing for HCV RNA will be carried out by an accredited specialist virology laboratory."
            },
            "type": "ListItem",
            "sequence_num": 98
        },
        {
            "data": {
                "is_heading": 0,
                "text": "HCW's who have active, or current infection (HCV RNA positive) will be restricted from performing EPPs."
            },
            "type": "ListItem",
            "sequence_num": 99
        },
        {
            "data": {
                "is_heading": 0,
                "text": "HCW's living with HCV who have been treated with antiviral therapy and who remain HCV RNA negative for at least 6 months after cessation of treatment are permitted to return to performing EPP after review by the OHP. A further check at 3 months will be made. The return to EPP work does not need to be referred to UKAP."
            },
            "type": "ListItem",
            "sequence_num": 100
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.6,
                "text": "HIV testing for HCW's who will perform EPP"
            },
            "type": "ListItem",
            "sequence_num": 101
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.6.1 New HCW's who intend to perform EPPs will be tested for HIV infection. The presence of HIV antibody does not automatically restrict HCWs from performing EPPs. Confirmation of HIV infection will be undertaken and the plasma viral load will be measured."
            },
            "type": "ListItem",
            "sequence_num": 102
        },
        {
            "data": {
                "is_heading": 0,
                "text": "HCWs living with HIV and a plasma viral load above 200 copies/mL should be restricted from performing EPPs."
            },
            "type": "ListItem",
            "sequence_num": 103
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Intial clearance to perform EPPs requires a HCW to be on effective combination anti retroviral therapy (cART) and to have 2 IVS test results taken no less than 12 weeks apart with both demonstrating a viral load below 200 copies /mL. The decision to clear individual HCWs to undertake EPPs is the responsibility of the consultant occupational physician. UKAP may be consulted as required."
            },
            "type": "ListItem",
            "sequence_num": 104
        },
        {
            "data": {
                "is_heading": 0,
                "text": "For HCW's currently restricted from EPPs who are already on cART and have viral load below the clearance threshold, one IVS at 12-16 weeks since their last undetectable viral load is sufficient proof on which to grant clearance on which to grant clearance for conducting EPPs."
            },
            "type": "ListItem",
            "sequence_num": 105
        },
        {
            "data": {
                "is_heading": 0,
                "text": "(See section 6 for monitoring HCW's performing EPPs who are living with HIV in line with the UKAP-OHR requirements)"
            },
            "type": "ListItem",
            "sequence_num": 106
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.7,
                "text": "Redeployment and retraining"
            },
            "type": "ListItem",
            "sequence_num": 107
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.7.1  If a HCW is unable to recommence EPP practice, the Trust will, where necessary make every effort to arrange suitable alternative work and re training opportunities, or where appropriate, early retirement. If short term redeployment is required whilst the HCW commences anti viral treatment, and until a point that their infection is cleared (HCV), or their viral load is reduced below the level required to perform EPPs, this will be arranged in conjunction with Human Resources."
            },
            "type": "ListItem",
            "sequence_num": 108
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "The model for allowing HCW's living with HBV or HIV to undertake EPPs whilst on therapy relies on continuing care and regular viral load monitoring by both their treating physician and consultant occupational health physician. Effective monitoring requires close working between these 2 parties to ensure the policy is being adhered to appropriately, thus minimising the risk of transmission."
            },
            "type": "ListItem",
            "sequence_num": 109
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.2,
                "text": "All HCWs living with HBV or HIV who perform EPPs will have their viral load measured regularly using a blood IVS."
            },
            "type": "ListItem",
            "sequence_num": 110
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.3,
                "text": "To support and monitor implementation of the policy and to ensure patient safety, all HCW's living with HBV or HIV including locum staff, who wish to perform EPPs (and for HCWs living with HBV, clinical duties in renal units or any other settings involving renal dialysis), and who meet the criteria for clearance, will be monitored locally and registered on the UKA-OHR, a central confidential register, managed by PHE (on behalf of Health Protection Scotland, Public Health Wales, and the Public Health Agency for Northern Ireland) and over seen by UKAP."
            },
            "type": "ListItem",
            "sequence_num": 111
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.4,
                "text": "Each HCW must be registered onto the UKAP-OHR by their designated consultant occupational health physician. Their ongoing viral load monitoring data will be reported to the UKAP-OHR by Occupational Health on a regular basis."
            },
            "type": "ListItem",
            "sequence_num": 112
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.1,
                "text": "Hepatitis B"
            },
            "type": "ListItem",
            "sequence_num": 113
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.1.1 HCWs who are HBsAg positive should not be restricted from performing EPPs or clinical duties in renal units or clinical settings where renal dialysis takes place if:"
            },
            "type": "ListItem",
            "sequence_num": 114
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.0,
                "text": "HBV DNA viral load is less than 200IU/mL (either from natural suppression, or  months after stopping a course of antiviral therapy), and"
            },
            "type": "ListItem",
            "sequence_num": 115
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.0,
                "text": "they are monitored every  calendar months by their consultant occupational health physician"
            },
            "type": "ListItem",
            "sequence_num": 116
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Or if:"
            },
            "type": "ListItem",
            "sequence_num": 117
        },
        {
            "data": {
                "is_heading": 0,
                "text": "they are on continuous antiviral therapy, and"
            },
            "type": "ListItem",
            "sequence_num": 118
        },
        {
            "data": {
                "is_heading": 0,
                "text": "their viral load is suppressed to below 200IU/mL, and"
            },
            "type": "ListItem",
            "sequence_num": 119
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.0,
                "text": "their HBV DNA levels are monitored every  weeks by their consultant occupational health physician"
            },
            "type": "ListItem",
            "sequence_num": 120
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The 12-week or 12 month monitoring period should be taken from the date the previous IVS was drawn, and not from the date the result was received."
            },
            "type": "ListItem",
            "sequence_num": 121
        },
        {
            "data": {
                "is_heading": 0,
                "text": "If a HCW's plasma viral load is above 200 IU/mL, they should be restricted immediately from performing EPPs until their viral load returns to being stable below 200 IU/mL (see Resuming EPPs). The significance of any increase in plasma viral load above the cut-off, identified through routine monitoring, should be assessed jointly by the consultant occupational health physician and treating physician with input from appropriate local experts (e.g. consultant virologist or microbiologist)."
            },
            "type": "ListItem",
            "sequence_num": 122
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The expected course of action for HBV DNA level test results uis outlined below:"
            },
            "type": "ListItem",
            "sequence_num": 123
        },
        {
            "type": "table",
            "sequence_num": 124,
            "data": {
                "num_rows": 4,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "HBV DNA LEVEL"
                    },
                    {
                        "text": "ACTION"
                    },
                    {
                        "text": "<60 IU/mL"
                    },
                    {
                        "text": "No action. Retest in 12 weeks or 12 months depending on antiviral treatment status"
                    },
                    {
                        "text": "<60 but <200 IU/mL"
                    },
                    {
                        "text": "A case by case approach based on clinical judgement will be taken which may result in no action (as above) or recommending that a second test should be done 10 days later to verify the viral load remains below the threshold. Further action will be informed by the test result."
                    },
                    {
                        "text": "200 IU/mL or above"
                    },
                    {
                        "text": "The HCW will cease conducting EPPs immediately. The Occupational Health Department will advise the manager that the staff member is cleared to conduct EPPs. A second test will be done on a new blood sample 10 days later to verify the viral load remains above 200 IU/mL. If the viral load is still in excess of 200 IU/mL, the HCW will cease conducting EPPs until the viral load, in 2 consecutive tests no less than 4 weeks apart, is reduced to <200 IU/mL. If the viral load is below 200 IU/mL then further action will be informed by the test result as above. If the test results are unexpected (e.g. from very high viral load to low viral load), then further advice from the virologist or UKAP secretariat will be sought. A full risk assessment will be triggered to determine the risk of HCW to patient transmission. At a minimum, this will include discussion between the consultant occupational health physician and the treating physician on the significance of the result in relation to risk of transmission. Public health investigation / action (e.g. patient notification) will be determined by a risk assessment on a case by case basis in discussion with UKAP."
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.1.2 Resuming exposure prone procedures."
            },
            "type": "ListItem",
            "sequence_num": 125
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 54.0,
                "text": "If a HCW does not attend for their monitoring appointment, then they should cease conducting EPPs.  weekly monitoring can be performed no later than  complete calendar weeks after the preceding IVS specimen taken for occupational health purposes.  monthly monitoring can be performed no later than  complete calendar weeks after the preceding IVS specimen taken for occupational health monitoring purposes."
            },
            "type": "ListItem",
            "sequence_num": 126
        },
        {
            "data": {
                "is_heading": 0,
                "text": "If a HCW does not attend for the missed viral load test within this timeframe (for whatever reason) then resumption of EPPs requires 2 IVS taken no less than 4 weeks apart with both showing a viral load result below 200 copies/mL."
            },
            "type": "ListItem",
            "sequence_num": 127
        },
        {
            "data": {
                "is_heading": 0,
                "text": "HCWs living wth HBV who take a career break from performing EPPs or clinical duties in renal units and or settings with renal dialysis, may wish to continue monitoring during this period to facilitate a return to EPPs or clinical activities. Individuals with a break in their monitoring record must meet the criteria for initial clearance before returning to perform EPPs or clinical duties in renal units or settings with renal dialysis."
            },
            "type": "ListItem",
            "sequence_num": 128
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.1.3 Treatment Issues"
            },
            "type": "ListItem",
            "sequence_num": 129
        },
        {
            "data": {
                "is_heading": 0,
                "text": "If breakthrough infections occur due to the development of resistant strains, and HBV DNA levels rise above 200 IU/mL, the HCW will be restricted from performing EPPs (or clinical duties in renal units or settings where there is renal dialysis) until such a time as they have been re-stabilised on different antiviral drugs. This is demonstrated by HBV DNA levels of less than 200 IU/mL on 2 consecutive tests performed no less than 4 weeks apart."
            },
            "type": "ListItem",
            "sequence_num": 130
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The manager will be informed of any EPP restrictions by Occupational Health Department."
            },
            "type": "ListItem",
            "sequence_num": 131
        },
        {
            "data": {
                "is_heading": 0,
                "text": "If a HCW stops antiviral treatment for any reason, they will cease to perform EPP's or clinical duties in renal units or settings that involve renal dialysis and should seek the advice of their treating physician. If the HBV DNA levels remain below 200 IU/mL a year after cessation of treatment, it may be appropriate to resume EPP duties, subject to a further test 6 calendar months later and annual testing thereafter. However, this will be decided by the occupational health physician and the EPP status will be confirmed to the manager."
            },
            "type": "ListItem",
            "sequence_num": 132
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.2,
                "text": "Hepatitis C"
            },
            "type": "ListItem",
            "sequence_num": 133
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.2.1 HCWs who have active or current infection (i.e. who are HCV RNA positive) will be restricted from carrying out EPPs."
            },
            "type": "ListItem",
            "sequence_num": 134
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.2.2 HCWs who have antibodies to the HCV and are confirmed as having a sustained viral response (i.e. who are HCV RNA negative), following treatment can perform EPPs."
            },
            "type": "ListItem",
            "sequence_num": 135
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.2.3 HCW's living with HCV who have been treated with antiviral therapy and who remain HCV RNA negative for a least 6 months after cessation of treatment will be permittee to return to performing EPPs at that time. A further check will be undertaken after 3 months."
            },
            "type": "ListItem",
            "sequence_num": 136
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.3,
                "text": "HIV"
            },
            "type": "ListItem",
            "sequence_num": 137
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.3.1 HCW's living with HIV must meet the following criteria in order to perform EPPs:"
            },
            "type": "ListItem",
            "sequence_num": 138
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Either"
            },
            "type": "ListItem",
            "sequence_num": 139
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Be on effective cART, and"
            },
            "type": "ListItem",
            "sequence_num": 140
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Have a plasma viral load <200 copies/mL"
            },
            "type": "ListItem",
            "sequence_num": 141
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Or"
            },
            "type": "ListItem",
            "sequence_num": 142
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Be an elite controller"
            },
            "type": "ListItem",
            "sequence_num": 143
        },
        {
            "data": {
                "is_heading": 0,
                "text": "And"
            },
            "type": "ListItem",
            "sequence_num": 144
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.0,
                "text": "Be subject to plasma viral load monitoring every  weeks"
            },
            "type": "ListItem",
            "sequence_num": 145
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Be under joint supervision of a consultant occupational health physician and their treating physician"
            },
            "type": "ListItem",
            "sequence_num": 146
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Be registered with UKAP-OHR"
            },
            "type": "ListItem",
            "sequence_num": 147
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.0,
                "text": "7.3.2 HCWs living with HIV who are cleared to perform EPPs are subject to viral load testing every  weeks while continuing to perform such procedures. The  week period will be taken from the date the previous IVS was drawn, and not from the date the result was received."
            },
            "type": "ListItem",
            "sequence_num": 148
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.0,
                "text": "7.3.3 If a HCW's plasma viral load rises above 1,000 copies/mL, performing EPP will be immediately restricted until the viral load returns to being consistently below 200 copies/mL in at least 2 consecutive tests no less than  weeks apart. The occupational health department will advise the HCW's line manager of the EPP restrictions."
            },
            "type": "ListItem",
            "sequence_num": 149
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The table below sets out the expected course of action for viral load test results."
            },
            "type": "ListItem",
            "sequence_num": 150
        },
        {
            "type": "table",
            "sequence_num": 151,
            "data": {
                "num_rows": 4,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "VIRAL LOAD TEST RESULT"
                    },
                    {
                        "text": "ACTION"
                    },
                    {
                        "text": "<50 copies/ml or below"
                    },
                    {
                        "text": "No action. Re test in 12 weeks"
                    },
                    {
                        "text": "\u226550 but <200 copies/mL"
                    },
                    {
                        "text": "Case by case approach based on clinical judgement by the occupational health physician. May result in no action (as above) or a recommendation for a second test 10 days later to verify the viral load remains below the threshold. Further action will be informed by the test result"
                    },
                    {
                        "text": "\u2265200 copies/mL but <1,000 copies/mL"
                    },
                    {
                        "text": "A second test will be completed 10 days later on a new blood sample to verify that the viral load remains above the threshold. If the count is still in excess of 200 copies/mL, the HCW will cease EPP work until their count, in 2 consecutive tests no less than 12 weeks apart, is reduced to <200 copies/mL."
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 152,
            "data": {
                "num_rows": 2,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": "If the viral load was below 200 copies/mL then further action will be informed by the test result as above. If test results are unexpected (e.g. from very high viral load to low viral load) further advice will be sought from the consultant virologist or UKAP secretariat."
                    },
                    {
                        "text": "1,000 copies/mL or above"
                    },
                    {
                        "text": "Immediate cessation of EPP. A second test will occur on a new blood sample 10 days later to verify the viral lead remains above 1,000 copies/mL. If the count is below 1,000 copies/mL further action will be informed by the test result as above. If test results are unexpected (e.g. from very high viral load to low viral load) further advice will be sought from the consultant virologist or UKAP secretariat. If the count is still in excess of 1,000 copies/mL a full risk assessment will take place to determine the risk of HCW to patient transmission. The occupational health consultant will discuss this with the treating physician. The need for further public health investigation / action (e.g. patient notification) will be determined by a risk assessment on a case by case basis in discussion with UKAP."
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "7.3.4 Resuming exposure prone procedures"
            },
            "type": "ListItem",
            "sequence_num": 153
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.0,
                "text": "If a HCW does not attend their monitoring appointment, EPP work should cease. The occupational health department will notify the HCW and relevant line manager.  weekly monitoring can be performed no later than  complete calendar weeks after the preceding IVS specimen taken for occupational health monitoring purposes."
            },
            "type": "ListItem",
            "sequence_num": 154
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.0,
                "text": "If a HCW does not attend for the missed viral load test within  weeks from the date the previous IVS was drawn, then resumption of EPPs requires demonstration of consistent viral load suppression to very low or undetectable levels, by 2 samples taken no less than 12 weeks apart demonstrating viral load below 200 copies/mL."
            },
            "type": "ListItem",
            "sequence_num": 155
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.0,
                "text": "HCW's living with HIV who take a career break of more than  weeks from performing EPPs may wish to continue  weekly monitoring during this period to facilitate a return to EPPs. Individuals with a break in their monitoring record must meet the criteria for intial clearance before returning to EPP activities."
            },
            "type": "ListItem",
            "sequence_num": 156
        },
        {
            "data": {
                "is_heading": 1,
                "text": "7.3.5 Treatment issues"
            },
            "type": "ListItem",
            "sequence_num": 157
        },
        {
            "data": {
                "is_heading": 0,
                "text": "If there is a suggestion that the HCW's infection is no longer controlled by their antiviral treatment, the treating physician may request viral load tests sooner than the next 12 week test. Advice on management of suspected treatment failure of suboptimal response will be sought from the specialist team."
            },
            "type": "ListItem",
            "sequence_num": 158
        },
        {
            "data": {
                "is_heading": 1,
                "text": "7.3.6 Elite Controllers"
            },
            "type": "ListItem",
            "sequence_num": 159
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Elite controllers comprise of a small proportion (0.2-0.55%) of all people living with HIV, who are not receiving antiretroviral therapy and have maintained their viral load below the limits of essay detection for at least 12 months, based on at least 3 separate viral load measurements."
            },
            "type": "ListItem",
            "sequence_num": 160
        },
        {
            "data": {
                "is_heading": 0,
                "text": "A HCW who meets the definition of being an elite controller can be cleared for EPP activities without being on treatment but must remain subject to 12 weekly viral load monitoring to ensure they maintain their viral load below 200 copies/mL and to identify any rebound promptly. The occupational health physician will refer to UKAP for advice on a case by case basis."
            },
            "type": "ListItem",
            "sequence_num": 161
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "Finding that a HCW has performed EPPs while living with HCV or that the viral load of a HCW living with HIV or HBV has risen above the cut-off for performing EPPs should be escalated to the Associate Director of Occupational Health and Wellbeing."
            },
            "type": "ListItem",
            "sequence_num": 162
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.2,
                "text": "The need for a PNE will be determined on a case by case basis and a risk assessment will be undertaken."
            },
            "type": "ListItem",
            "sequence_num": 163
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "Accidental exposure to a patient by a HCW living with a bloodborne virus will be managed in line with the sharps and needlestick injury policy and in consultation with the local health protection team."
            },
            "type": "ListItem",
            "sequence_num": 164
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "When transferring OH monitoring a HCW living with a BBV to a new OH service or healthcare organisation, the current consultant occupational physician will consider including in the transfer summary:"
            },
            "type": "ListItem",
            "sequence_num": 165
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Approximate dates of employment and clearance"
            },
            "type": "ListItem",
            "sequence_num": 166
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Consent of HCW to transfer UKAP-OHR registration"
            },
            "type": "ListItem",
            "sequence_num": 167
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Confirmation that the UKAP-OHR team have been informed of the transfer"
            },
            "type": "ListItem",
            "sequence_num": 168
        },
        {
            "data": {
                "is_heading": 0,
                "text": "UKAP-OHR reference number"
            },
            "type": "ListItem",
            "sequence_num": 169
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Consent of HCW to transfer the HCWs EPP related health records"
            },
            "type": "ListItem",
            "sequence_num": 170
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Medical and treatment history including medication changes and compliance"
            },
            "type": "ListItem",
            "sequence_num": 171
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Testing history including points of note e.g. historical actions or tests needed"
            },
            "type": "ListItem",
            "sequence_num": 172
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Confirmation that the new consultant occupational physician is accredited in occupational medicine"
            },
            "type": "ListItem",
            "sequence_num": 173
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Contact details of the treating doctor"
            },
            "type": "ListItem",
            "sequence_num": 174
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Any other concerns or details necessary."
            },
            "type": "ListItem",
            "sequence_num": 175
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "If a HCW who is subject to monitoring wishes to stop undertaking EPPs, for example because of moving jobs, they are recommended to formally inform their current consultant occupational health physician. HCWs should also consider providing the reason for halting monitoring and the date of stopping EPPs, including confirmation from the employer about their new non-EPP role. Those who are self- employed could provide a self-statement confirming their new non-EPP role. The consultant occupational health physician will notify the HCW and UKAP-OHR when monitoring will cease."
            },
            "type": "ListItem",
            "sequence_num": 176
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.1,
                "text": "There is a general duty to preserve the confidentiality of medical information and records. Breach of this duty is very damaging for the individuals concerned, and it undermines the confidence of the public and of HCWs in the assurances about confidentiality which are given to those who come forward for examination or treatment."
            },
            "type": "ListItem",
            "sequence_num": 177
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.2,
                "text": "Occupational Health records are held separately from other hospital notes and can be accessed only by occupational health practitioners, who are obliged ethically and professionally not to release records or information without the consent of the individual."
            },
            "type": "ListItem",
            "sequence_num": 178
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.3,
                "text": "Every effort should be made to avoid disclosure of the HCW's identity or information which would allow deductive disclosure. Any unauthorised disclosure about the BBV status of an employee constitutes a breach of confidence and may lead to disciplinary action."
            },
            "type": "ListItem",
            "sequence_num": 179
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.4,
                "text": "The duty of confidentiality, however, is not absolute. Legally, the identity of individuals living with BBVs may be disclosed with their consent, or without consent in exceptional circumstances, where it is considered necessary for the purpose of treatment, the prevention of spread of infection or in the public interest where patients are, or may have been, at risk. Any such disclosure will need to be justified and based on a robust assessment of the risk to patient(s)."
            },
            "type": "ListItem",
            "sequence_num": 180
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.5,
                "text": "In balancing duty to the HCW living with a BBV and the wider duty to the public, complex ethical issues may arise. As in other areas of medical practice, a HCW disclosing information about another HCW will be required to justify their decision to do this. The need for disclosure must be carefully weighed and where there is any doubt the HCW considering such disclosure may wish to seek advice from his or her professional body."
            },
            "type": "ListItem",
            "sequence_num": 181
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.6,
                "text": "The duties of confidentiality still apply even if the HCW has died or has already been identified publicly."
            },
            "type": "ListItem",
            "sequence_num": 182
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.1,
                "text": "Occupational health staff receive in house and external training as appropriate."
            },
            "type": "ListItem",
            "sequence_num": 183
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.1,
                "text": "Outlined below is the Trust's process of monitoring compliance with, and  the effectiveness of the document's main points."
            },
            "type": "ListItem",
            "sequence_num": 184
        },
        {
            "type": "table",
            "sequence_num": 185,
            "data": {
                "num_rows": 2,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Aspect of compliance or effectiveness being monitored"
                    },
                    {
                        "text": "Monitoring Method"
                    },
                    {
                        "text": "Individual department responsible for the monitoring"
                    },
                    {
                        "text": "Frequency of the monitoring activity"
                    },
                    {
                        "text": "Group / Committee / forum which will receive the findings/monitoring report"
                    },
                    {
                        "text": "Committee / individual responsible for ensuring the actions are completed"
                    },
                    {
                        "text": "Audit and monitoring of health clearance of new HCW with EPP roles"
                    },
                    {
                        "text": "Audit"
                    },
                    {
                        "text": "OH"
                    },
                    {
                        "text": "Annual"
                    },
                    {
                        "text": "OH leads meeting"
                    },
                    {
                        "text": "OH leads meeting"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.1,
                "text": "All policies, procedures and guidelines will be approved by the Infection Control Committee which is the specialist group with the authority to approve local policies and guidelines. These will then be forwarded to the Document control team for submission and ratification by the Joint Document Management Group."
            },
            "type": "ListItem",
            "sequence_num": 186
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.2,
                "text": "It is the author's responsibility to inform the HR Policy Working Group of the approved policy documents when they are uploaded to the Trust's Intranets."
            },
            "type": "ListItem",
            "sequence_num": 187
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.1,
                "text": "The Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals."
            },
            "type": "ListItem",
            "sequence_num": 188
        },
        {
            "data": {
                "is_heading": 0,
                "text": "(Refer to appendix Doc control admin to complete)"
            },
            "type": "ListItem",
            "sequence_num": 189
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Department of Health (2007) Health clearance for tuberculosis, hepatitis B, hepatitis C and HIV: New healthcare workers. Department of Health March 2007"
            },
            "type": "ListItem",
            "sequence_num": 190
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Public Health England (2020) Integrated guidance on health clearance of health care workers and the management of healthcare workers living with bloodborne viruses (hepatitis B, hepatitis C and HIV). Giudance from UKAP. August 2020."
            },
            "type": "ListItem",
            "sequence_num": 191
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Policy for the health clearance and management of health care workers living with bloodborne viruses (Hepatitis B, Hepatitis C and HIV)/ MSEPO-21047 / 1.0"
            },
            "type": "ListItem",
            "sequence_num": 192
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 23.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 193
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Policy for the health clearance and management of health care workers living with bloodborne viruses (Hepatitis B, Hepatitis C and HIV)/ MSEPO-21047 / 1.0"
            },
            "type": "ListItem",
            "sequence_num": 194
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix1: Preliminary equality analysis"
            },
            "type": "ListItem",
            "sequence_num": 195
        },
        {
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to: Policy for the health clearance and management of health care workers living with bloodborne viruses (Hepatitis B, Hepatitis C and HIV)/MSEPO-21047"
            },
            "type": "ListItem",
            "sequence_num": 196
        },
        {
            "data": {
                "is_heading": 0,
                "text": "(please tick all that apply)"
            },
            "type": "ListItem",
            "sequence_num": 197
        },
        {
            "type": "table",
            "sequence_num": 198,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2610 A change in a service to patients"
                    },
                    {
                        "text": "\u2610 A change to an existing document"
                    },
                    {
                        "text": "\u2610 A change to the way staff work"
                    },
                    {
                        "text": "\u2612 A new document"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 199,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Harmonise policy"
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "Ensure consistent practice"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Staff and patients"
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "Yes"
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": "Refer to pages 1 & 2. Relevant professional leads"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 200,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Teresa Dowdeswell"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Interim Deputy Manager OH"
                    },
                    {
                        "text": "Date: 14 January 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 21.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 201
        }
    ]
}